The processes of the body do not all work in isolation, and hence a holistic approach is needed to optimise treatment for an individual patient. Sub optimal processes in one part of the body have the potential to impact another part of the body. Environmental changes can also have an impact. For example poor food choices have the potential to reduce the effectiveness of the gut bacteria to digest food, and the dysfunction or "dysbiosis" of the gut is thought to contribute to chronic diseases including diabetes and CKD.

Medlab is at the forefront of a new treatment paradigm which views the function of the gut as central to many of the processes in the body and the starting point for many chronic diseases that have nothing to do with the stomach. The gut and its chemical messengers have connections to the brain for example. Metabolic processes such as glucose metabolism are affected by gut bacteria. By improving the function of the gut, Medlab aims to modify the course of chronic diseases.

Medicines utilising good bacteria, also known as probiotics, are under investigation in a number of research programs around the world, but none are yet approved as Prescription Medicines for early intervention to stop the progression of chronic diseases, under the supervision of a doctor. This will require completion of rigorous clinical trials to demonstrate specific health benefits. Probiotics are extremely well tolerated, which is an important attribute of medicine for early intervention.

In the digital age, the empowered consumer is increasingly knowledgeable about their health and is often willing to pay for treatments that maintain their health, and avoid potential side effects of current drugs especially for chronic diseases.

An increasing focus of the "young elderly" on maintaining health extends to a desire to avoid the effects of pain and aging. It is likely that many older people will be willing to pay an amount similar to "a cup of coffee a day" for a proven medicine that will enable them to feel younger, such as a treatment to reduce muscle aging. For this reason the revenue growth is not reliant on re-imbursement from health payors.